Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Mucositis × Standard of Care × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Head & Neck 1

Conditions

Prostatic Neoplasms 7 Breast Neoplasms 7 Lung Neoplasms 5 Head and Neck Neoplasms 5 Neoplasms 4 Leukemia, Myeloid, Acute 4 Hematologic Neoplasms 3 Colorectal Neoplasms 3 Recurrence 2 Pulmonary Disease, Chronic Obstructive 2 Neoplasm Metastasis 2 Leukemia 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Xerostomia 1 Urologic Neoplasms 1 Urologic Diseases 1 Urogenital Neoplasms 1 Urinary Bladder Neoplasms 1 Urinary Bladder Diseases 1 Teratoma 1 Stroke 1 Stomatitis 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Sarcoma 1 Rectal Neoplasms 1 Radiation Injuries 1 Prostatic Diseases 1

Interventions

oxycodone-acetaminophen 1 cyclohexaneacetic acid 1 acetaminophen, hydrocodone drug combination 1 Sucralfate 1 Standard of Care 1 Radiotherapy 1 Passive Cutaneous Anaphylaxis 1 Pain Management 1 Morphine 1 Methods 1 Methadone 1 Ketamine 1 Ibuprofen 1 Hydromorphone 1 Glutamine 1 Gabapentin 1 Fibroblast Growth Factor 7 1 Fentanyl 1 Educational Status 1 Early Intervention, Educational 1 Benzydamine 1 Analgesia 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01917942 2017-07-12

RadioHum

Trans Tasman Radiation Oncology Group

Phase 3 Completed

Head & NeckOther

Head and Neck Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡